| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |